Low Testosterone in Men: It’s More Than Just Low Sex Drive

Medically reviewed by Courtney A. Washington, DO | Last reviewed November 5, 2026

Category: Men's Health | Hormone Health | Behind the Science | Updated: October 19, 2026

Can low testosterone affect more than a man’s sex drive?

Absolutely. Testosterone plays important roles in muscle development, bone health, sexual function, red blood cell production, and emotional well-being. Low levels can contribute to fatigue, decreased strength, reduced libido, and changes in mood. But these symptoms may also signal underlying metabolic or cardiovascular conditions that deserve more than a prescription for testosterone.

What Happens When a Man’s Testosterone Starts Declining?

Imagine being a man in your 40s or 50s who has always been relatively active.

Lately, your workouts feel harder. You’re gaining weight around your abdomen, losing muscle definition, and struggling to maintain the same energy you once had.

Maybe your sex drive isn’t what it used to be. You’re more irritable, less motivated, or simply don’t feel like yourself.

You might assume you’re getting older, working too hard, or just need more sleep.

But what if your hormones are playing a role?

Testosterone levels generally decline gradually as men age, although the pattern varies considerably between individuals.

For some men, that decline contributes to a condition known as hypogonadism, in which the body does not produce adequate testosterone.

The important distinction is that aging and testosterone deficiency are not automatically the same thing.

And low testosterone deserves attention because its effects can extend well beyond the bedroom.

What Are the Symptoms of Low Testosterone in Men?

Testosterone affects multiple systems throughout the body.

Symptoms that may occur with testosterone deficiency include:

  • Decreased sexual desire or fewer spontaneous morning erections
  • Difficulty achieving or maintaining erections
  • Reduced muscle mass and strength
  • Increased body fat
  • Fatigue or decreased physical endurance
  • Low motivation, depressed mood, or irritability
  • Reduced bone density and increased fracture risk
  • Unexplained anemia
  • Difficulty concentrating or reduced overall sense of well-being

Not every man experiences the same symptoms.

And not every man with fatigue, weight gain, or erectile dysfunction has low testosterone.

Sleep apnea, diabetes, thyroid disorders, depression, medication effects, and other conditions can produce similar symptoms.

The diagnosis requires both compatible symptoms and consistently low testosterone levels—not simply feeling tired or getting older.

Why Is Testosterone So Important for Muscle Development?

Testosterone is an anabolic hormone, meaning it helps the body build and maintain tissue, including skeletal muscle.

It influences muscle protein synthesis, supports lean body mass, and contributes to strength and physical performance.

When testosterone is significantly reduced, some men experience declining muscle mass and increasing fat accumulation.

That can create a frustrating cycle.

Less muscle may make physical activity more difficult. Reduced activity can contribute to additional weight gain and worsening metabolic health.

Clinical trials have demonstrated that testosterone replacement in appropriately selected men with hypogonadism can improve lean body mass and certain measures of physical function.

However, testosterone is not a substitute for resistance training, adequate protein intake, sleep, or metabolic health management.

Hormones help create the conditions for muscle maintenance, but lifestyle still matters.

Can Low Testosterone Affect a Man’s Mood and Emotional Health?

Yes, although the relationship is more complicated than many people realize.

Testosterone influences neural pathways involved in motivation, sexual behavior, and emotional functioning.

Some men with testosterone deficiency describe feeling less energetic, less confident, or less interested in activities they once enjoyed.

Others report irritability, depressed mood, or difficulty concentrating.

Imagine experiencing these changes while trying to manage a career, support your family, maintain a relationship, and keep up with everyday responsibilities.

It can be difficult, particularly when you don’t understand why you’re feeling different.

Research suggests testosterone replacement can modestly improve depressive symptoms in some men, but it is not an established stand-alone treatment for major depressive disorder.

Mood changes should never automatically be attributed to testosterone.

Men’s emotional health deserves the same thoughtful evaluation as their physical health.

Sometimes hormone deficiency is part of the picture. Sometimes it isn’t.

Does Erectile Dysfunction Always Mean You Need the Little Blue Pill?

Not necessarily.

Medications such as sildenafil (Viagra) and tadalafil (Cialis) work by improving the blood-flow response needed for an erection.

They can be effective treatments for erectile dysfunction (ED), but they don’t address every possible underlying cause.

An erection involves several interacting systems:

  • Healthy blood vessels and adequate circulation
  • Normal nerve signaling
  • Psychological and emotional functioning
  • Appropriate hormonal activity

Testosterone deficiency may contribute to reduced sexual desire and fewer spontaneous erections.

However, erectile dysfunction is often related to vascular disease, diabetes, hypertension, medication effects, or psychological factors.

And here’s something I want more men to understand:

Erectile dysfunction may be an early warning sign of cardiovascular disease.

The 2024 Princeton IV Consensus Guidelines emphasize that erectile dysfunction should be considered a marker of cardiovascular risk.

Why?

Because the blood vessels supplying the penis are smaller than the coronary arteries.

Vascular dysfunction may therefore become noticeable through changes in erectile function before a man develops recognizable symptoms of coronary artery disease.

So, while a prescription for an erectile dysfunction medication may help, it shouldn’t automatically replace a broader health evaluation.

For some men, the more important question is not simply, “How do we improve the erection?”

It’s, “What is this symptom telling us about your overall health?”

Can Obesity Lower Testosterone and Increase Estrogen in Men?

Yes, and this is one of the most interesting relationships in male hormone health.

Body fat isn’t simply stored energy. Adipose tissue is metabolically active and produces enzymes and signaling molecules that influence hormone balance.

One important enzyme is called aromatase.

Aromatase converts certain androgens, including testosterone, into estrogens such as estradiol.

As body fat increases, aromatase activity may increase, resulting in greater conversion of testosterone to estrogen.

Obesity can also suppress normal testosterone production through inflammatory and metabolic mechanisms, including changes in sex hormone-binding globulin and the hypothalamic-pituitary-gonadal axis.

The result may be lower circulating testosterone and altered estrogen-to-androgen balance.

In some men, this contributes to gynecomastia—the development of glandular breast tissue.

However, not every man with obesity develops elevated estrogen, and excess chest fat is not always true gynecomastia.

Fat accumulation over the chest without glandular breast enlargement is called pseudogynecomastia.

Gynecomastia can also result from medications, liver disease, and other hormonal conditions.

This is why weight management, sleep, insulin resistance, and hormone health should be evaluated together rather than treated as unrelated problems.

For some men with obesity-related functional testosterone suppression, meaningful weight loss can improve testosterone levels without requiring testosterone replacement.

Do Men Need Estrogen Too?

Absolutely.

Although estrogen is commonly associated with women’s health, it plays important roles in men as well.

Men produce estradiol primarily through the conversion of testosterone by aromatase.

Estradiol contributes to bone maintenance and is involved in reproductive and metabolic physiology.

It also participates in pathways relevant to vascular function.

This brings us to an interesting question:

Could differences in estrogen levels help explain why men often develop heart disease earlier than women?

Before menopause, women generally have substantially higher circulating estrogen concentrations than men.

Estrogen influences blood vessel function, nitric oxide signaling, and aspects of lipid metabolism.

These effects may contribute to some of the cardiovascular differences observed between premenopausal women and similarly aged men.

Following menopause, estrogen levels decline significantly, and women’s cardiovascular risk rises with age.

But the relationship is not as simple as saying estrogen prevents heart attacks.

Both men and women develop atherosclerosis—the buildup of cholesterol-rich plaque and inflammation within arterial walls.

The disease process involves many of the same factors: high blood pressure, diabetes, abnormal cholesterol, smoking, chronic inflammation, and metabolic dysfunction.

Sex hormones may influence the timing and progression of these processes, but they are not the only explanation.

The important point is that both testosterone and estrogen contribute to male physiology. Hormonal balance matters more than simply trying to maximize testosterone or suppress estrogen.

Testosterone or estradiol should not be prescribed to men for the purpose of preventing heart attacks based on the evidence currently available.

Does Testosterone Replacement Increase Heart Attack Risk?

This has been one of the most debated questions in men’s hormone health.

In 2023, the landmark TRAVERSE randomized trial examined cardiovascular outcomes among more than 5,200 men with confirmed hypogonadism who had existing cardiovascular disease or increased cardiovascular risk.

The researchers compared testosterone gel with placebo.

Major adverse cardiovascular events occurred in approximately 7.0% of men assigned testosterone and 7.3% assigned placebo.

The trial demonstrated that testosterone therapy was not inferior to placebo for major cardiovascular events over the study’s follow-up period.

These findings influenced the FDA’s February 2025 decision to remove language concerning increased cardiovascular risk from testosterone products’ boxed warnings.

However, the study did identify increased occurrences of certain adverse events, including atrial fibrillation, pulmonary embolism, and acute kidney injury in the testosterone group.

Testosterone products may also increase blood pressure and hematocrit, requiring appropriate monitoring.

The evidence is reassuring for appropriately selected men with confirmed testosterone deficiency, but it does not establish that testosterone treatment prevents heart disease or is free of cardiovascular risks.

Does Testosterone Cause Prostate Cancer? What Does the New Research Show?

For decades, concerns about prostate cancer have strongly influenced testosterone prescribing.

Because prostate cancer cells can respond to androgen signaling, testosterone therapy was historically approached with considerable caution.

But newer studies are helping clarify the relationship.

A 2023 randomized analysis from the TRAVERSE trial, published in JAMA Network Open, evaluated prostate-related outcomes in more than 5,200 men with hypogonadism.

During the study, researchers did not find statistically significant differences in high-grade prostate cancer, overall prostate cancer, or several other prostate outcomes between testosterone and placebo groups.

Importantly, men with known prostate cancer or higher-risk prostate findings were excluded.

These results therefore cannot be generalized to every man, particularly those with existing or high-risk prostate cancer.

What Did the New 2026 Prostate Cancer Study Find?

In May 2026, JAMA Internal Medicine published a randomized clinical trial involving 136 men who had undergone radical prostatectomy for low-grade prostate cancer and also had hypogonadism.

The researchers evaluated short-term testosterone treatment.

Men receiving testosterone experienced improvements in sexual desire, sexual activity, physical function, and aerobic performance.

No biochemical recurrence was observed during treatment or the short follow-up period.

That is encouraging.

But the treatment lasted only 12 weeks, with approximately three additional months of follow-up. The study was not large enough or long enough to determine whether testosterone affects long-term prostate cancer recurrence.

The emerging evidence is challenging older assumptions about testosterone and prostate cancer, but it does not establish that testosterone therapy is safe for every prostate cancer survivor.

In June 2026, the FDA requested further testosterone labeling updates addressing prostate cancer and benign prostatic hyperplasia risks.

These developments support more individualized discussions—not abandoning prostate screening, monitoring, or appropriate precautions.

How Do You Know if Your Testosterone Is Actually Low?

A proper evaluation begins with symptoms and medical history.

Testing generally includes an early-morning total testosterone measurement, when levels are typically highest.

Because testosterone fluctuates, an abnormal result should generally be confirmed with a second early-morning measurement.

Depending on the clinical circumstances, additional testing may include:

  • Free testosterone and sex hormone-binding globulin
  • Luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
  • Prolactin when indicated
  • Complete blood count and metabolic testing
  • Thyroid studies, glucose, and lipid evaluation when appropriate
  • Estradiol when clinically indicated, particularly with gynecomastia

A comprehensive assessment should also consider medication use, sleep apnea, obesity, testicular disorders, and pituitary conditions.

Testosterone replacement may be appropriate for men with confirmed hypogonadism after discussing risks, benefits, fertility goals, and monitoring.

One especially important consideration is fertility.

Exogenous testosterone can suppress sperm production and should not be started without discussing reproductive plans.

Treatment also requires appropriate monitoring of testosterone levels, hematocrit, clinical response, and prostate health when indicated.

Dr. Co’s Perspective: Men’s Health Is More Than a Testosterone Number

As a family medicine physician, I believe we need to have more open conversations about men’s hormonal health.

Too often, a man comes in complaining of fatigue, weight gain, erectile dysfunction, or decreased motivation and receives treatment for one symptom without a broader evaluation.

Sometimes he receives a prescription for erectile dysfunction. Sometimes he’s told to lose weight. Other times, he’s reassured that it’s simply aging.

But what if these symptoms are connected?

What if abdominal obesity, insulin resistance, disrupted sleep, reduced testosterone, and erectile dysfunction are all part of a larger clinical picture?

That’s where comprehensive primary care matters.

I also want men to understand that changes in sexual function or physical performance do not diminish their masculinity.

Hormones can affect how you feel physically and emotionally, and struggling with these changes doesn’t mean you lack discipline or motivation.

At the same time, testosterone isn’t a miracle treatment.

A man with normal testosterone levels may not benefit from supplementation, and unnecessary treatment can create real risks.

What excites me about newer research is that we’re moving toward a more informed discussion of testosterone, cardiovascular health, and prostate cancer.

We’re recognizing that older assumptions deserve reconsideration while continuing to demand strong evidence.

My goal is not simply to raise a man’s testosterone level. It’s to understand what’s affecting his health, address reversible causes, and help him regain the best possible quality of life.

And sometimes that means treating low testosterone. Other times, it means addressing diabetes, sleep apnea, obesity, cardiovascular risk, or mental health.

That’s what individualized medicine should look like.

The Doctor’s Dose: What You Need to Know

  1. Low testosterone is about more than sex drive. It can affect muscle mass, sexual function, bone health, energy, and emotional well-being. Diagnosis requires symptoms and confirmed low hormone levels.
  2. Erectile dysfunction and obesity may reveal larger health concerns. ED can be an early marker of cardiovascular disease, while obesity can alter testosterone and estrogen balance. Treating the underlying cause matters.
  3. Testosterone research is evolving. Large cardiovascular and prostate safety trials provide encouraging findings for appropriately selected men, but therapy still requires careful evaluation and monitoring.

The Conversation Doesn’t End Here

Whether you’re noticing changes in your own health or supporting a husband, partner, father, or brother who doesn’t seem quite like himself, understanding male hormonal health is an important first step.

Don’t assume that fatigue, reduced sexual function, or loss of muscle strength must simply be accepted as aging.

And don’t assume testosterone replacement is always the answer.

Start with a conversation and an appropriate medical evaluation.

For more evidence-based information about hormones, metabolic health, longevity, and preventive medicine, explore AskDrCo.com.

To learn more about individualized men’s hormone health consultations, visit Fleur-De-Lis Aesthetics.

Evidence over opinions.

When you don’t know… Ask Dr. Co.

Scientific References

  1. Lincoff AM, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. New England Journal of Medicine. 2023;389:107–117.
    https://doi.org/10.1056/NEJMoa2215025
  2. Bhasin S, et al. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Network Open. 2023;6(12).
    https://doi.org/10.1001/jamanetworkopen.2023.48692
  3. Bhasin S, et al. Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism: A Randomized Clinical Trial. JAMA Internal Medicine. 2026;186(7):805–814.
    https://doi.org/10.1001/jamainternmed.2026.1343
  4. Kloner RA, et al. Princeton IV Consensus Guidelines: PDE5 Inhibitors and Cardiac Health. Journal of Sexual Medicine. 2024;21(2):90–116.
    https://doi.org/10.1093/jsxmed/qdad163
  5. Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. 2018;103(5):1715–1744.
    https://doi.org/10.1210/jc.2018-00229
  6. U.S. Food and Drug Administration. FDA Issues Class-Wide Labeling Changes for Testosterone Products. February 28, 2025.
    https://www.fda.gov/drugs/drug-alerts-and-statements/fda-issues-class-wide-labeling-changes-testosterone-products
  7. U.S. Department of Health and Human Services. HHS Announces Requested Updates to Testosterone Therapy Product Labels. June 18, 2026.
    https://www.hhs.gov/press-room/fda-requests-updates-testosterone-therapy-labeling.html
  8. U.S. Food and Drug Administration. Testosterone Information. Updated 2026.
    https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/testosterone-information

Medical disclaimer: This article is intended for educational purposes only and does not replace individualized medical advice. Testosterone treatment should be considered only after an appropriate medical evaluation and discussion of potential benefits, risks, and monitoring requirements.

Facebook
Twitter
Email
Print
Picture of Courtney Washington, DO
Courtney Washington, DO

Leave a Reply

Your email address will not be published. Required fields are marked *